Multiple ongoing clinical trials of various potential targets of CAR T-cell therapy for colorectal cancer, including solid tumor targets such as GUCY2C, CEA, and TAG-72 and circulating tumor cell targets such as EpCAM, are shown in Table 1. The gene discussed is CEACAM5; the disease is neoplasm.